Equities

Inari Medical Inc

Inari Medical Inc

Actions
  • Price (EUR)38.40
  • Today's Change-0.40 / -1.03%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 08:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments115326176
Total Receivables, Net705942
Total Inventory433321
Prepaid expenses6.485.315.69
Other current assets, total0.61----
Total current assets236423245
Property, plant & equipment, net697261
Goodwill, net214----
Intangibles, net151----
Long term investments1.508.303.98
Note receivable - long term------
Other long term assets2.620.590.98
Total assets674504312
LIABILITIES
Accounts payable117.666.54
Accrued expenses664936
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total------
Total current liabilities765643
Total long term debt000
Total debt000
Deferred income tax36----
Minority interest------
Other liabilities, total973130
Total liabilities2098772
SHAREHOLDERS EQUITY
Common stock0.060.050.05
Additional paid-in capital504463257
Retained earnings (accumulated deficit)(48)(47)(18)
Treasury stock - common------
Unrealized gain (loss)----(0.02)
Other equity, total8.890.85(0.38)
Total equity465417239
Total liabilities & shareholders' equity674504312
Total common shares outstanding585450
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.